Alerts will be sent to your verified email
Verify EmailZENITHDRUG
Zenith Drugs
|
Mercury Laboratories
|
Samrat Pharmachem
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
22.97 % | 10.51 % | 20.36 % |
5yr average Equity Multiplier
|
4.46 | 1.49 | 1.97 |
5yr Average Asset Turnover Ratio
|
1.16 | 1.05 | 2.61 |
5yr Avg Net Profit Margin
|
4.99 % | 6.6 % | 3.99 % |
Price to Book
|
0.0 | 1.87 | 1.36 |
P/E
|
11.49 | 26.48 | 20.39 |
5yr Avg Cash Conversion Cycle
|
-99.3 Days | -4.69 Days | 59.17 Days |
Inventory Days
|
53.1 Days | 32.68 Days | 27.69 Days |
Days Receivable
|
141.66 Days | 115.65 Days | 78.39 Days |
Days Payable
|
298.39 Days | 157.73 Days | 45.36 Days |
5yr Average Interest Coverage Ratio
|
4.04 | 15.15 | 14.72 |
5yr Avg ROCE
|
30.01 % | 13.49 % | 30.03 % |
5yr Avg Operating Profit Margin
|
9.39 % | 11.74 % | 5.83 % |
5 yr average Debt to Equity
|
1.14 | 0.13 | 0.26 |
5yr CAGR Net Profit
|
25.02 % | -10.08 % | -12.62 % |
5yr Average Return on Assets
|
5.56 % | 7.02 % | 10.58 % |
Shareholdings
|
|||
Promoter Holding
|
69.98 % | 73.66 % | 49.09 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | -0.56 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Zenith Drugs
|
Mercury Laboratories
|
Samrat Pharmachem
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
-
|
Distribution Channel
|
Distribution Channel
|
-
|
-
|